On ECHEMI
Home > Drugs > Anhui Globe Pharmaceutical Co., Ltd.
Anhui Globe Pharmaceutical Co., Ltd.
  • Founded in:

    2000-11-13
  • Country:

    China China
  • Address:

    No. 3809 Huangshan Avenue, Bengbu City
  • Tax NO.:

    91340300723348633W
  • Registered Funds:

    98.5 million yuan
  • Website:

  • Email:

Related Drugs
Compound Licorice Oral Solution
This product is a compound preparation. Each bottle contains: 1100ml contains 5g glucose and 0.9g sodium chloride. 2100ml contains 10g glucose and 0.9g sodium chloride. 3250ml contains 12.5g glucose and 2.25g sodium oxide. 4250ml contains 25g glucose and 2.25g sodium chloride. 5500ml contains 25g glucose and 4.5g sodium chloride. 6500ml contains 50g glucose and 4.5g sodium chloride. Auxiliary: water for injection.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Glucose is one of the main sources of calories for the human body

More

Glucose is one of the main sources of calories for the human body

5g/1100ml, 10g/2100ml, 12.5g/250ml, 25g/250ml, 25g/500ml, 50g/500mlg/ml 58367-01-4 15
Sodium chloride

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

More

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

0.9g/1100ml, 0.9g/2100ml, 2.25g/250ml, 2.25g/250ml, 4.5g/500ml, 4.5g/500mlg/ml 7647-14-5 43
Bromhexine Hydrochloride Tablets
Each tablet of this product contains 8 mg of bromhexine hydrochloride. The auxiliary materials are starch, sucrose, hypromellose, magnesium stearate, microcrystalline cellulose, dextrin, and micro-powder silica gel.
Name Description Content CAS NO. Registered Holders
Bromhexine hydrochloride

This product acts directly on the bronchial glands, can release the lysosomes of mucus secreting cells, thereby depolymerizing the mucopolysaccharides in the mucus and reducing the viscosity of the mucus; it can also cause the respiratory tract to secrete low-viscosity small-molecule mucins, making the sputum thinner and easier to cough up.

More

This product acts directly on the bronchial glands, can release the lysosomes of mucus secreting cells, thereby depolymerizing the mucopolysaccharides in the mucus and reducing the viscosity of the mucus; it can also cause the respiratory tract to secrete low-viscosity small-molecule mucins, making the sputum thinner and easier to cough up.

8mg 611-75-6 26
Irbesartan Tablets
Irbesartan.
Name Description Content CAS NO. Registered Holders
Irbesartan

Irbesartan is a potent, orally active, selective angiotensin-II receptor (AT1 subtype) antagonist that blocks all AT1 receptor-mediated angiotensin-II effects. Its selective antagonism of angiotensin-II receptors (AT1) leads to increased plasma renin and angiotensin-II levels and decreased plasma aldosterone levels. Irbesartan does not inhibit angiotensin-converting enzyme (ACE kininase II), which generates angiotensin-II, and can also degrade bradykinin into inactive metabolites. Irbesartan's activity does not require metabolic activation, and there is no evidence of abnormal body or target organ toxicity when used at clinically relevant doses.

More

Irbesartan is a potent, orally active, selective angiotensin-II receptor (AT1 subtype) antagonist that blocks all AT1 receptor-mediated angiotensin-II effects. Its selective antagonism of angiotensin-II receptors (AT1) leads to increased plasma renin and angiotensin-II levels and decreased plasma aldosterone levels. Irbesartan does not inhibit angiotensin-converting enzyme (ACE kininase II), which generates angiotensin-II, and can also degrade bradykinin into inactive metabolites. Irbesartan's activity does not require metabolic activation, and there is no evidence of abnormal body or target organ toxicity when used at clinically relevant doses.

138402-11-6 65
Irbesartan Tablets
The main ingredient of this product is irbesartan.
Name Description Content CAS NO. Registered Holders
Irbesartan

This product is an angiotensin II (Ang II) receptor inhibitor, which can inhibit the conversion of Ang I to Ang II, and can specifically antagonize angiotensin converting enzyme 1 receptor (AT1). Its antagonism to AT1 is greater than AT28500 times. It selectively blocks the binding of Ang II to AT1 receptor, inhibits vasoconstriction and the release of aldosterone, and produces a hypotensive effect. This product does not inhibit angiotensin converting enzyme (ACE), renin, other hormone receptors, nor does it inhibit ion channels related to blood pressure regulation and sodium balance.

More

This product is an angiotensin II (Ang II) receptor inhibitor, which can inhibit the conversion of Ang I to Ang II, and can specifically antagonize angiotensin converting enzyme 1 receptor (AT1). Its antagonism to AT1 is greater than AT28500 times. It selectively blocks the binding of Ang II to AT1 receptor, inhibits vasoconstriction and the release of aldosterone, and produces a hypotensive effect. This product does not inhibit angiotensin converting enzyme (ACE), renin, other hormone receptors, nor does it inhibit ion channels related to blood pressure regulation and sodium balance.

138402-11-6 65
Procaterol Hydrochloride Tablets
The main ingredient of this product is Procaterol hydrochloride, and its chemical name is 5-(1-hydroxy-2-isopropylaminobutyl)-8-carboxyquinolone hydrochloride hemihydrate. Molecular formula: C16H22N2O3·HCL·1/2H20. Molecular weight: 335.83.
Name Description Content CAS NO. Registered Holders
Procaterol hydrochloride

This product is a β2 receptor agonist with a high selectivity for the β2 adrenergic receptors of bronchial smooth muscle, thereby relaxing the bronchial smooth muscle; it also has a certain anti-allergic effect and promotes respiratory cilia movement.

More

This product is a β2 receptor agonist with a high selectivity for the β2 adrenergic receptors of bronchial smooth muscle, thereby relaxing the bronchial smooth muscle; it also has a certain anti-allergic effect and promotes respiratory cilia movement.

81262-93-3 6
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.